Cooper CJ, Denyer SP, Maillard JY, Rapid and quantitative automated measurement of bacteriophage activity against cystic fibrosis isolates of Pseudomonas aeruginosa. J Appl Microbiol. 2011 Mar;110(3):631-40. doi: 10.1111/j.1365-2672.2010.04928.x. Epub 2011 Jan 12.

Cheeseman KE, Denyer SP, Hosein IK, Williams GJ, Maillard JY, Evaluation of the bactericidal efficacy of three different alcohol hand rubs against 57 clinical isolates of S. aureus. J Hosp Infect. 2009 Aug;72(4):319-25. doi: 10.1016/j.jhin.2009.04.018. Epub 2009 Jul 10.

McGann P, Rozak DA, Nikolich MP, Bowden RA, Lindler LE, Wolcott MJ, Lathigra R, A novel brain heart infusion broth supports the study of common Francisella tularensis serotypes, J. Microbiol Methods. 2010 Feb: 80(2): 164-171. Epub 2009 Dec 11. PMID: 20005265 [PubMed - in process]

Prior S, Gander B, Lecároz C, et. al., Gentamicin-loaded microspheres for reducing the intracellular Brucella abortus load in infected monocytes, Journal of Antimicrobial Chemotherapy (2004) 53, 981-988. (CN00216)

Geisler N, Gattringer R, Graninger W, Georgopoulos A, Linezolid in combination with vancomycin and teicoplanin against MRSA by spectrophotometric optical density measurements, Austrian Health Communication, Antibiotika Monitor - 3/4/2003, 10th Scientific Meeting of European Society of Chemotherapy, Poster Session, Poster P 80. (CN00278)

Geisler N, Gattringer R, Graninger W, Georgopoulos A, [Wirksamkeit von Teicoplanin oder Vancomycin in Kombination mit Linezolid gegenüber Methicillin-resistentem Staphylococcus aureus mittels spektrophotometrischer Trübungsmessung] (Ger.), Austrian Health Communication, Antibiotika Monitor - 6/2003, Teicoplanin als First-Line-Antibiotikum. (CN00507)

Odenholt I, Gustafsson I, Löwdin E, Postantibiotic and Sub-MIC Effects of Benzylpenicillin against Streptococcus pneumoniae with Different Susceptibilities for Penicillin, Chemotherapy 2003;49:287-293. (CN00334)

Odenholt I, Löwdin E, Cars O, Postantibiotic, Postantibiotic Sub-MIC, and Subinhibitory Effects of PGE-9509924, Ciprofloxacin, and Levofloxacin, Antimicrobial Agents and Chemotherapy, October 2003, p. 3352-3356, Vol. 47, No. 10. (CN00336)

Qvarnström Y, Sulphonamide Resistance in Neisseria meningitidis and Commensal Neisseria Species, Acta Universitatis Upsaliensis, Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine, 1301, 47 pp, 2003, Uppsala, ISBN 91-554-5783-5. (CN00396)

Rabsch W, Methner U, Voigt W, Tschape H, Reissbrodt R, Williams PH, Role of receptor proteins for enterobactin and 2,3-dihydroxybenzoylserine in virulence of Salmonella enterica, Infect Immun. 2003 Dec;71(12):6953-6961 . (CN00371)

Walsh SE, Maillard JY, Russell AD, Catrenich CE, Charbonneau DL, Bartolo RG, Activity and mechanisms of action of selected biocidal agents on Gram-positive and -negative bacteria, Journal of Applied Microbiology, 2003 Feb, vol. 94, No. 2, pp. 240-247 . (CN00034)

Daelemans D, Afonina E, Nilsson J, Werner G, Kjems J, De Clercq E, Pavlakis GN, Vandamme AM, A synthetic HIV-1 Rev inhibitor interfering with the CRM1-mediated nuclear export, Reprint (PDF):, Proceedings of the National Academy of Sciences, USA, Vol. 99, Issue 22, 14440-14445, October 29, 2002, Published online before print October 9, 2002, 10.1073/pnas.212285299. (CN00030)

Kuipers ME, Beljaars L, Van Beek N, et. al., Conditions influencing the in vitro antifungal activity of lactoferrin combined with antimycotics against clinical isolates of Candida, Apmis, Volume 110, Issue 4, Page 290-298, April 2002. (CN00127)

Meylaers K, Cerstiaens A, Vierstraete E, Baggerman G, Michiels CW, De Loof A, Schoofs L, Antimicrobial Compounds of Low Molecular Mass are Constitutively Present in Insects: Characterisation of ß-Alanyl-Tyrosine, Current Pharmaceutical Design, 2002, 8, pp. 99-110. (CN00060)

Meylaers K, Cerstiaens A, Vierstraete E, Baggerman G, Michiels CW, De Loof A, Schoofs L, Antimicrobial compounds of low molecular mass are constitutively present in insects: characterisation of beta-alanyl-tyrosine, Current Pharmaceutical Design, 2002, 8, pp. 99-110. (CN00061)

Alander M, Mättö J, Kneifel W, et. al., Effect of galacto-oligosaccharide supplementation on human faecal microflora and on survival and persistence of Bifidobacterium lactis Bb-12 in the gastrointestinal tract,International Dairy Journal, Volume 11, Issue 10 , 2001, Pages 817-825. (CN00162)

Aroutcheva A, Gariti D, Simon M, et. al., Defense factors of vaginal lactobacilli, American Journal of Obstetrics & Gynecology, 185(2):375-379, August 2001. (CN00138)

Charteris WP, Kelly PM, Morelli L, Collins JK, Antibacterial activity associated with Lactobacillus gasseri ATCC 9857 from the human female genitourinary tract, World Journal of Microbiology and Biotechnology (2001), 17(6), 615-625. (CN00050)

Georgopoulos A, Graninger W, Bezecny P, Buxbaum A, In vitro activity of fosfomycin combined with glycopeptides, moxifloxacin, gentamicin and ampicillin against Enterococci, assessed by the modified spectrophotometric method, Poster, Wien, Austria, 2001, Abstract: P540, 1 pp. Citation: Clinical Microbiology and Infection, volume 7, supplement 1, 2001, (394 pp). (CN00252)

Lambert RJW, Joynson J, Forbes B, The relationships and susceptibilities of some industrial, laboratory and clinical isolates of Pseudomonas aeruginosa to some antibiotics and biocides, Journal of Applied Microbiology, Volume 91, Issue 6, Page 972-984, Dec 2001. (CN00429)

Matinaho S, von Bonsdorff L, Rouhiainen A, et. al., Dependence of Staphylococcus epidermidis on non-transferrin-bound iron for growth,FEMS Microbiology Letters 196 (2001) pp. 177-182. (CN00139)

Simoes JA, Aroutcheva AA, Shott S, Faro S, Effect of metronidazole on the growth of vaginal lactobacilli in vitro, Infectious Diseases in Obstetrics and Gynecology, 2001, 9: 41-45. (CN00164)

Chiron J, Lamande J, Moussa F, Trivin F, Ceolin R, [Effect of micronized C60 fullerene on the microbial growth in vitro] (French), Annales pharmaceutiques francaises, 2000, May, 58(3), 170-175. (CN00483)

Gelfand EB, . Tsedenzhapov ETs, Karabak VI, et. al., [Efficacy of Meropenem in the Management of Abdominal Sepsis in Surgical Patients] (Russ.), Antibiotiki i Chimoterapia (Russ.), 2000, 45; 5. (CN00484)

Georgopoulos A, Bezecny P, Buxbaum A, Graninger W, [Aktivität von Fosfomycin in Kombination mit Ampicillin, Gentamicin, Moxifloxacin, Vancomycin und Teicoplanin gegenüber Enterokokken mittels Bioscreen-C-Analyzer] (Ger.), Austrian Health Communication, Antibiotika Monitor - 5/6/2000. (CN00472)

Parkkinen J, von Bonsdorff L, Peltonen S, et. al., Catalytically active iron and bacterial growth in serum of haemodialysis patients after i.v. iron–saccharate administration, Nephrol Dial Transplant (2000) 15: 1827-1834. (CN00106)

Blomqvist G, Wesslen L, Påhlson C, et. al., Phylogenetic Placement and Characterization of a New Alpha-2 Proteobacterium Isolated from a Patient with Sepsis, Journal of Clinical Microbiology, Aug. 1997, p. 1988-1995. (CN00328)

Lundberg JON, Carlsson S, Engstrand L, et. al., Urinary nitrite: more than a marker of infection, Urology, Volume 50, Issue 2, August 1997, Pages 189-191. (CN00450)

Minelli EB, Benini A, Bassi C, et. al., Antimicrobial activity of human pancreatic juice and its interaction with antibiotics, Antimicrobial Agents and Chemotherapy, 1996, vol. 40, (9), pp. 2099-2105. (CN00055)

Van Eldere J, Joosten L, Verhaeghe A, Surmont I, Fluconazole and Amphotericin B antifungal susceptibility testing by National Committee for Clinical Laboratory Standards broth macrodilution method commpared with E-test and semiautomated broth microdilution test, Journal of Clinical Microbiology, 1996, vol. 34, (4), pp. 842-847. (CN00199)

Kingsley R, Rabsch W, Stephens P, et. al., Iron supplying systems of Salmonella in diagnostics, epidemiology and infection, FEMS Immunology and Medical Microbiology, 1995, vol. 11, pp. 257-264. (CN00272)

Odenholt-Tornqvist I, Studies on the postantibiotic effect and the postantibiotic sub-MIC effect of meropenem, Journal of Antimicrobial Chemotherapy 31: (1993) 881-892. (CN00393)

Antonov VS, Kulikova TA, Shestakova LA, Shibanov AN, [A method of determining the degree of bacteriuria and its detection using the Bioscreen system], (Russ.), Antibiotiki i Khimoterapija, 1991, vol. 36, (4), pp. 28-30. (CN00471)

Antonov VS, Kulikova TA, Shestakova LA, Shibanov AN, [Procedure for detection of bacteriuria and estimation of its level with the Bioscreen system](Russ.), Antibiotiki i Himoterapija, 1991, vol. 36, (4), pp. 28-30. (CN00496)

Hedin G, Hambraeus A, Screening tests for the detection of methicillin resistance in Staphylococcus epidermis, Chemotherapy, 1991, vol. 28, (5), pp. 681-694. (CN00375)

Scalarone GM, Mikami Y, Kurita N, Ichihara Y, Yazawa K, Miyaji M, Turbidometric characterization of the postantifungal effect: comparative studies with amphotericin B, 5-fluorocytosine and miconazole on Candida albicans, (Eng.),Mycoses, 1991, vol. 34, pp. 297-302. (CN00448)

Inoue M, Okubo T, Hashimoto H, [In vitro antibacterial activity of new macrolide antibiotic, rokitamycin] 28th ICAAC (Los Angeles)(jap), Toyo Jozo Co., Ltd, (904), 1988, 4-6 November, pp. 21-29. (CN00488)

Viljanen M, Procedure for automatic measuring of the minimum inhibitory concentrations (MIC) of twenty antimicrobial agents by Bioscreen,University of Turku, 1986, pp. 6. (CN00341)

Okubo T, Suzuki T, Fujita K, Iyobe S, Inoue M, Postantibiotic effects (PAE's) of macrolide antibiotics evaluated using Bioscreen C method, Japanese J. of Antibiotics, vol. 48, (4), pp. 548-52. (CN00335)

Wejdemar K, Vitamins that stimulate the growth of Butyrivibrio fibrisolvens strains grown in rumen fluid, Swedish University of Agricultural Sciences, Department of Animal Nutrition and Management, Kungsängen Research Station; report, 1 pp. (CN00466)

©2015 Growth Curves USA